{
    "type": "ETF",
    "ucits": true,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": false,
    "leverage": false,
    "inverse": false,
    "complex_factors": [
        "Unfunded Swaps",
        "Synthetic Replication",
        "Counterparty Risk"
    ],
    "classification": "complex",
    "supporting_data": "The Invesco STOXX Europe 600 Optimised Chemicals UCITS ETF uses unfunded swap agreements as a core part of its investment strategy to synthetically replicate the STOXX Europe 600 Optimised Chemicals Index. The KIID explicitly states the use of unfunded swaps with counterparty exposure and derivative counterparty risk, which are key complexity indicators under MiFID II. The replication method is synthetic, confirmed by the factsheet, which also highlights swap fees and counterparty risk. There is no leverage or inverse exposure, and derivatives are used inherently in the strategy rather than solely for risk management, so 'derivatives' is marked false per instructions. The fund is UCITS compliant and invests primarily in equities but does not physically replicate the index, instead relying on swap contracts. The risk profile is medium-high (risk category 6 in KIID), reflecting the complexity and counterparty risk. The PRIIPs KID confirms no capital protection or structured features but reiterates the reliance on swap counterparties and the absence of capital guarantees. The factsheet confirms the synthetic replication method, swap fee of 10% p.a., and the presence of counterparty risk. No leverage or inverse exposure is present. The complexity arises mainly from the synthetic replication via unfunded swaps and the associated counterparty risk, which may be difficult for retail investors to fully understand, fulfilling MiFID II criteria for complexity."
}